UroGen Pharma has opened another front in its attack on bladder cancer, paying IconOVir Bio $4 million in stock for an ...

There are around 2,800 new cases of malignant glioma ... participated in the clinical trial programme. It is the first oncolytic virus therapy to be launched anywhere in the world for brain ...

It's not the first therapy in the oncolytic virus class to be approved around the world, as that accolade went to Amgen's Imlygic (talimogene laherparepvec), which was cleared by the FDA for the ...

Imugene's trial programs could result in the first 'off the shelf' Car-T therapy that uses healthy donors' cells.

Versa, the global leader in Universal Secure Access Service Edge (SASE), today announced the general commercial availability of Versa Sovereign SASEtm, uniquely allowing enterprises, governments, and ...

Candel Therapeutics' lead candidate CAN-2409 shows promising results in several indications. Find out why I rate CADL stock ...

The virus is related to the pathogen that causes Middle East respiratory syndrome and capitalizes on the same ‘entry receptor ...

The Human Virome Program will analyze samples from thousands of volunteers in an effort to understand how viruses affect health.

Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local doctors and hospitals.

Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments ...

NHN(KRX: 181710, CEO Ujin Chung) is excited to announce the upcoming global test for its new zombie apocalypse game, ?Darkest Days' scheduled for February. The game will enter its open beta test (OBT) ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...